Manjula M Venkatappa | Nanotechnology | Young Scientist Award

Published on by Top Pharmaceutical

 

Young Scientist Award

Manjula M Venkatappa
Affiliation Saint Louis University
Country India
Google Scholar ID UHqSN-oAAAAJ
Documents 27
Citations 408
h-index 11
Subject Area Nanotechnology
Event International Top Pharmaceutical Awards
Scopus 57443895000

Manjula M Venkatappa – Saint Louis University

Manjula M Venkatappa is a researcher whose reported scholarly work is associated with nanotechnology, biochemistry, oxidative-stress biology, natural products, and biologically synthesized nanoparticles. Her publication record includes studies investigating metal and metal-oxide nanoparticles and their potential biological activities. Several publications have examined antioxidant, anti-inflammatory, antithrombotic, and related pharmacological effects in experimental models. These research themes provide a relevant scientific basis for consideration within a pharmaceutical research recognition framework.

Abstract

Manjula M Venkatappa’s research profile reflects interdisciplinary activity connecting nanotechnology with biomedical and pharmaceutical science. Her publications include investigations of green-synthesized magnesium oxide, titanium dioxide, cobalt ferrite, copper ferrite, and zinc ferrite nanoparticles. These studies have considered nanoparticle characterization together with biological outcomes such as oxidative stress modulation, inflammation, thrombosis, and cancer-cell responses. Such work illustrates the potential role of nanotechnology-enabled approaches in pharmaceutical and biomedical research.

Keywords

Nanotechnology; Nanoparticles; Green Synthesis; Nanomedicine; Oxidative Stress; Antioxidant Activity; Anti-inflammatory Activity; Antithrombotic Research; Cancer Biology; Biochemistry; Natural Products; Pharmaceutical Research; Biomedical Nanotechnology.

Introduction

Nanotechnology has become an important research area in pharmaceutical and biomedical sciences because nanoscale materials can provide distinctive physicochemical and biological properties. Green synthesis approaches are particularly relevant where researchers seek to use biological materials as reducing, stabilizing, or capping agents. Venkatappa’s published studies have explored this research direction through plant-mediated synthesis and evaluation of several nanoparticle systems. Her work therefore contributes to a broader scientific discussion concerning nanomaterials and their possible biomedical applications [1].

Research Profile

The reported profile combines nanotechnology with experimental biochemistry and biological evaluation. A notable component of the publication record involves green-fabricated nanoparticles produced using botanical extracts and subsequently evaluated using biochemical or cellular models. Research has included magnesium oxide, titanium dioxide, cobalt ferrite, copper ferrite, and zinc ferrite nanoparticle systems. The studies indicate an interest in linking material synthesis and characterization with measurable biological effects [2].

Research Contributions

One contribution concerns the investigation of biofunctional magnesium oxide nanoparticles produced through green synthesis. The study evaluated oxidative-stress-induced tissue damage and thrombosis, providing a biological framework for examining the activity of nanoscale materials [1]. Another publication investigated green-synthesized titanium dioxide nanoparticles and their relationships with oxidative stress, inflammation, and human breast cancer proliferation [2]. Together, these studies demonstrate a consistent interest in biologically relevant nanoparticle systems.

Publications

Selected publications associated with Manjula M Venkatappa demonstrate a progression from nanoparticle synthesis and characterization toward biological and pharmacological evaluation. The publication record includes peer-reviewed articles addressing metal-oxide and ferrite nanoparticles, oxidative stress, inflammation, thrombosis, and cancer-related biological responses. DOI identifiers provide persistent links to the corresponding scholarly records. These publications form an appropriate evidence base for evaluating the researcher’s contribution to nanotechnology-oriented pharmaceutical research.

Research Impact

The reported scholarly indicators of 408 citations and an h-index of 11 suggest measurable academic visibility for the supplied research profile. Citation counts and h-index values can change over time and should therefore be interpreted as dynamic bibliometric indicators rather than permanent measures of research quality. The publications themselves provide additional evidence of interdisciplinary engagement across nanotechnology, biochemistry, and biomedical investigation. This combination is relevant to pharmaceutical research areas concerned with nanoscale materials and biological activity.

Award Suitability

The research profile is potentially suitable for consideration for the Young Scientist Award under the International Top Pharmaceutical Awards because its documented publication themes intersect with pharmaceutical nanotechnology and biomedical applications. The evidence includes peer-reviewed studies on green-synthesized nanoparticles and their experimentally evaluated biological activities. In particular, research involving oxidative stress, inflammation, thrombosis, and cancer-related responses provides clear connections to pharmaceutical and therapeutic research. Final award decisions should be based on the organizers’ eligibility requirements, verified bibliometric records, originality, scientific quality, and the complete submitted research portfolio.

Conclusion

Manjula M Venkatappa’s reported research portfolio demonstrates an interdisciplinary focus on nanotechnology and biological applications. Her publications cover multiple nanoparticle platforms and investigate experimentally relevant outcomes involving oxidative stress, inflammation, thrombosis, and cancer biology. The combination of nanomaterial development and biological evaluation is closely aligned with emerging pharmaceutical nanotechnology research. On the supplied evidence, the profile represents a relevant candidate for scholarly recognition within a pharmaceutical research award framework.

References

  1. Google Scholar. (n.d.). Manjula M Venkatappa: Google Scholar profile.
    https://scholar.google.com/citations?user=UHqSN-oAAAAJ&hl=en
  2. Venkatappa, M. M., Udagani, C., Hanume Gowda, S. M., Venkataramaiah, S., et al. (2023). Green synthesised TiO2 nanoparticles-mediated Terenna asiatica: Evaluation of their role in reducing oxidative stress, inflammation and human breast cancer proliferation. Molecules, 28(13), 5126.
    https://doi.org/10.3390/molecules28135126
  3. Venkatappa, M. M., Udagani, C., Hanumegowda, S. M., Pramod, S. N., et al. (2022). Effect of biofunctional green synthesized MgO-nanoparticles on oxidative-stress-induced tissue damage and thrombosis. Molecules, 27(16), 5162.
    https://doi.org/10.3390/molecules27165162
  4. Venkataramaiah, S., Venkatappa, M. M., Udagani, C., & Sannaningaiah, D. (2024). Green-synthesized cobalt ferrite nanoparticle alleviated sodium nitrite-induced oxidative stress through its anti-oxidant property and displayed anti-inflammatory, anti-diabetic and anti-platelet activities. Journal of Superconductivity and Novel Magnetism, 37(11), 1839–1857.
    https://doi.org/10.1007/s10948-024-06813-7
  5. Venkataramaiah, S., Venkatappa, M. M., Rangappa, R., Udagani, C., et al. (2025). Green fabricated bimetallic zinc ferrite nanoparticles mitigate oxidative stress-induced pathogenesis. Analytical Biochemistry, 700, 115767.
    https://doi.org/10.1016/j.ab.2025.115767

Walter Manucha | Nanopharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

Walter Manucha
National Scientific and Technical Research Council, Argentina
Walter Manucha
Affiliation National Scientific and Technical Research Council
Country Argentina
Scopus ID 57195218813
Documents 2665
Citations 3316
h-index 34
Subject Area Nanopharmacology
Event International Top Pharmaceutical Awards
ORCID 0000-0002-2279-7626

Walter Manucha is a researcher affiliated with the National Scientific and Technical Research Council in Argentina, with academic contributions associated with nanopharmacology, biomedical sciences, and translational therapeutic research. His scholarly profile reflects extensive publication activity, interdisciplinary scientific collaboration, and measurable citation performance within international indexing systems.[1] The recognition associated with the Best Researcher Award acknowledges sustained research productivity, scientific influence, and contributions to pharmaceutical and biomedical advancement within an international academic framework.[2]

Abstract

The Best Researcher Award article documents the academic profile and research standing of Walter Manucha in the field of nanopharmacology and pharmaceutical sciences. The article summarizes publication metrics, scholarly influence, interdisciplinary contributions, and international research visibility indexed through global academic databases.[1] It also evaluates the researcher’s suitability for recognition under the International Top Pharmaceutical Awards framework, emphasizing scientific productivity, citation impact, and contributions to biomedical innovation.[2]

Keywords

Nanopharmacology, Pharmaceutical Sciences, Biomedical Research, Drug Delivery, Translational Medicine, Scopus Metrics, Scientific Impact, Research Excellence, International Awards, Academic Recognition

Introduction

Academic recognition programs in pharmaceutical sciences frequently evaluate candidates using publication performance, citation analysis, interdisciplinary collaboration, and international scientific influence. Walter Manucha’s research activities are associated with nanopharmacology and therapeutic innovation, areas that continue to contribute to modern biomedical and pharmaceutical development.[1] Through indexed scholarly publications and measurable citation metrics, the researcher demonstrates sustained participation in peer-reviewed scientific advancement and international academic communication.[3]

Research Profile

Walter Manucha is affiliated with the National Scientific and Technical Research Council in Argentina and has developed a research profile connected to nanopharmacology, pharmaceutical sciences, and biomedical investigation. The Scopus-indexed profile records substantial publication activity and measurable scholarly visibility through citations and h-index indicators.[1] His academic contributions demonstrate participation in multidisciplinary scientific collaboration and translational research themes relevant to therapeutic sciences and clinical innovation.[4]

  • Institutional affiliation with the National Scientific and Technical Research Council.
  • Research specialization associated with nanopharmacology and biomedical sciences.
  • Scopus-indexed publication and citation visibility.
  • International academic dissemination and interdisciplinary collaboration.

Research Contributions

The researcher’s scientific activities contribute to areas related to drug development, therapeutic mechanisms, biomedical applications, and pharmaceutical innovation. Nanopharmacology represents an emerging interdisciplinary field integrating nanotechnology with pharmacological sciences to improve targeted therapeutic approaches and biomedical efficiency.[4] The research output associated with Walter Manucha reflects scholarly engagement with evolving pharmaceutical technologies and evidence-based biomedical methodologies.[5]

  • Development of interdisciplinary biomedical research frameworks.
  • Contributions to therapeutic and pharmaceutical sciences.
  • Scientific dissemination through indexed journal publications.
  • Participation in internationally recognized research communication platforms.

Publications

The publication record associated with Walter Manucha reflects extensive participation in scholarly communication and indexed scientific literature. Indexed databases identify numerous publications linked to pharmaceutical sciences and biomedical research themes.[1] Publication visibility and citation engagement indicate active dissemination within the international scientific community.[3]

  1. Research articles in nanopharmacology and biomedical sciences.
  2. Peer-reviewed publications indexed in international databases.
  3. Collaborative scientific contributions in pharmaceutical research.
  4. Publications contributing to translational and therapeutic innovation.

Research Impact

Research impact indicators demonstrate measurable academic visibility through citation performance, indexed publications, and h-index evaluation. Citation activity associated with the researcher indicates that published works have contributed to ongoing scientific discussion and scholarly reference within related biomedical domains.[1] The h-index score further reflects sustained research productivity and academic engagement over time.[3]

  • Scopus-indexed visibility and citation accumulation.
  • Sustained publication activity within pharmaceutical sciences.
  • Research dissemination through international scholarly networks.
  • Academic influence reflected through measurable bibliometric indicators.

Award Suitability

The Best Researcher Award recognizes sustained scientific contribution, publication excellence, and measurable academic impact within pharmaceutical and biomedical sciences. Walter Manucha’s documented research metrics, publication record, and interdisciplinary scientific involvement demonstrate alignment with the evaluative principles commonly associated with international academic recognition programs.[2] The researcher’s profile indicates scholarly consistency, international indexing visibility, and participation in evidence-based scientific advancement relevant to nanopharmacology and translational biomedical research.[5]

Conclusion

Walter Manucha’s academic profile reflects sustained scientific productivity, interdisciplinary collaboration, and measurable scholarly visibility within pharmaceutical and biomedical sciences. Through indexed publications, citation performance, and contributions associated with nanopharmacology, the researcher demonstrates continued engagement with internationally recognized scientific research activities.[1] The documented academic metrics and research dissemination support recognition under the Best Researcher Award category within the International Top Pharmaceutical Awards framework.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Walter Manucha, Author ID 57195218813. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195218813
  2. International Top Pharmaceutical Awards. (n.d.). Academic recognition and pharmaceutical research excellence platform.
    https://toppharmaceutical.org/
  3. Martín Gimenez, V. M., García Menendez, S., & Manucha, W. (2026). Multi-endogenous nanoformulation for endocannabinoid and hormonal modulation of key signaling pathways in resistant hypertension. Current Pharmaceutical Design.
    https://doi.org/10.2174/0113816128396666250728074858
  4. Reiter, R. J., Sharma, R., Loh, D., Chuffa, L. G. A., Bai, Y., Zuccari, D. A. P. C., Galano, A., & Manucha, W. (2026). Melatonin targets mitochondrial redox homeostasis: Optimizing the intracellular microenvironment. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms27104496
  5. Carloni, S., Luchetti, F., Nasoni, M. G., Balduini, W., Manucha, W., & Reiter, R. J. (2026). Melatonin and mitochondrial stress: New insights into age-related neurodegeneration. Neural Regeneration Research.
    https://doi.org/10.4103/NRR.NRR-D-24-01380